Innate Pharma earnings per share and revenue

IPHYF earnings per share for the last semiannual are -0.13 USD whereas the estimation was -0.45 USD which accounts for 70.25% surprise. Företagets omsättning för samma period uppgår till 23.64 M USD trots den uppskattade siffran 18.57 M USD. Estimated earnings per share for the next semiannual are -0.35 USD, and revenue is expected to reach 10.99 M USD. Also watch annual changes over time to get a bigger picture of IPHYF earnings per share and revenue dynamics.